Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
158.14
+2.14 (1.37%)
Nov 21, 2024, 1:44 PM EST - Market open
Biogen Analyst Ratings
Total Analysts
25
Consensus Rating
Buy
Price Target
$260.48
Upside
+64.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy → Hold Downgrades $270 | Strong Buy → Hold | Downgrades | $270 | +70.73% | Nov 18, 2024 |
| Baird | Baird | Buy Maintains $294 → $300 | Buy | Maintains | $294 → $300 | +89.71% | Nov 15, 2024 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 15, 2024 |
| Citigroup | Citigroup | Hold Initiates $190 | Hold | Initiates | $190 | +20.15% | Nov 14, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $220 → $210 | Hold | Maintains | $220 → $210 | +32.79% | Nov 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $270 → $255 | Buy | Maintains | $270 → $255 | +61.25% | Oct 31, 2024 |
| Barclays | Barclays | Hold Maintains $190 → $180 | Hold | Maintains | $190 → $180 | +13.82% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $300 → $275 | Strong Buy | Maintains | $300 → $275 | +73.90% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $300 | Strong Buy | Reiterates | $300 | +89.71% | Oct 31, 2024 |
| Needham | Needham | Strong Buy Reiterates $270 | Strong Buy | Reiterates | $270 | +70.73% | Oct 31, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $285 → $204 | Buy → Hold | Downgrades | $285 → $204 | +29.00% | Oct 31, 2024 |
| Needham | Needham | Strong Buy Reiterates $270 | Strong Buy | Reiterates | $270 | +70.73% | Oct 30, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $260 → $230 | Buy | Maintains | $260 → $230 | +45.44% | Oct 17, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $292 → $269 | Buy | Maintains | $292 → $269 | +70.10% | Oct 4, 2024 |
| UBS | UBS | Hold Maintains $234 → $202 | Hold | Maintains | $234 → $202 | +27.73% | Oct 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.